Biotechblog

Genentech's CEO on Big Pharma's Issues

Yali Friedman

Genentech’s CEO on Big Pharma’s Issues
Arthur Levinson tackles drug pricing, patent disputes, consumer marketing, and stem-cell research

Exit mobile version